279 related articles for article (PubMed ID: 33529165)
1. RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.
Patel PS; Abraham KJ; Guturi KKN; Halaby MJ; Khan Z; Palomero L; Ho B; Duan S; St-Germain J; Algouneh A; Mateo F; El Ghamrasni S; Barbour H; Barnes DR; Beesley J; Sanchez O; Berman HK; Brown GW; Affar EB; Chenevix-Trench G; Antoniou AC; Arrowsmith CH; Raught B; Pujana MA; Mekhail K; Hakem A; Hakem R
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529165
[TBL] [Abstract][Full Text] [Related]
2. RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells.
Krishnan R; Lapierre M; Gautreau B; Nixon KCJ; El Ghamrasni S; Patel PS; Hao J; Yerlici VT; Guturi KKN; St-Germain J; Mateo F; Saad A; Algouneh A; Earnshaw R; Shili D; Seitova A; Miller J; Khosraviani N; Penn A; Ho B; Sanchez O; Hande MP; Masson JY; Brown GW; Alaoui-Jamali M; Reynolds JJ; Arrowsmith C; Raught B; Pujana MA; Mekhail K; Stewart GS; Hakem A; Hakem R
Nucleic Acids Res; 2023 Oct; 51(19):10484-10505. PubMed ID: 37697435
[TBL] [Abstract][Full Text] [Related]
3. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
[TBL] [Abstract][Full Text] [Related]
4. RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1.
Muñoz MC; Laulier C; Gunn A; Cheng A; Robbiani DF; Nussenzweig A; Stark JM
J Biol Chem; 2012 Nov; 287(48):40618-28. PubMed ID: 23055523
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.
Zong D; Adam S; Wang Y; Sasanuma H; Callén E; Murga M; Day A; Kruhlak MJ; Wong N; Munro M; Ray Chaudhuri A; Karim B; Xia B; Takeda S; Johnson N; Durocher D; Nussenzweig A
Mol Cell; 2019 Mar; 73(6):1267-1281.e7. PubMed ID: 30704900
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability, defective spermatogenesis, immunodeficiency, and cancer in a mouse model of the RIDDLE syndrome.
Bohgaki T; Bohgaki M; Cardoso R; Panier S; Zeegers D; Li L; Stewart GS; Sanchez O; Hande MP; Durocher D; Hakem A; Hakem R
PLoS Genet; 2011 Apr; 7(4):e1001381. PubMed ID: 21552324
[TBL] [Abstract][Full Text] [Related]
7. The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors.
De Soto JA; Wang X; Tominaga Y; Wang RH; Cao L; Qiao W; Li C; Xu X; Skoumbourdis AP; Prindiville SA; Thomas CJ; Deng CX
Int J Biol Sci; 2006; 2(4):179-85. PubMed ID: 16810332
[TBL] [Abstract][Full Text] [Related]
8. RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of
Krais JJ; Wang Y; Bernhardy AJ; Clausen E; Miller JA; Cai KQ; Scott CL; Johnson N
Cancer Res; 2020 Jul; 80(13):2848-2860. PubMed ID: 32213544
[No Abstract] [Full Text] [Related]
9. Poly(ADP-ribosyl)ation links the chromatin remodeler SMARCA5/SNF2H to RNF168-dependent DNA damage signaling.
Smeenk G; Wiegant WW; Marteijn JA; Luijsterburg MS; Sroczynski N; Costelloe T; Romeijn RJ; Pastink A; Mailand N; Vermeulen W; van Attikum H
J Cell Sci; 2013 Feb; 126(Pt 4):889-903. PubMed ID: 23264744
[TBL] [Abstract][Full Text] [Related]
10. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.
Reid LJ; Shakya R; Modi AP; Lokshin M; Cheng JT; Jasin M; Baer R; Ludwig T
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20876-81. PubMed ID: 19088202
[TBL] [Abstract][Full Text] [Related]
11. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Davies H; Glodzik D; Morganella S; Yates LR; Staaf J; Zou X; Ramakrishna M; Martin S; Boyault S; Sieuwerts AM; Simpson PT; King TA; Raine K; Eyfjord JE; Kong G; Borg Å; Birney E; Stunnenberg HG; van de Vijver MJ; Børresen-Dale AL; Martens JW; Span PN; Lakhani SR; Vincent-Salomon A; Sotiriou C; Tutt A; Thompson AM; Van Laere S; Richardson AL; Viari A; Campbell PJ; Stratton MR; Nik-Zainal S
Nat Med; 2017 Apr; 23(4):517-525. PubMed ID: 28288110
[TBL] [Abstract][Full Text] [Related]
12. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
[TBL] [Abstract][Full Text] [Related]
13. Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining.
Zong D; Callén E; Pegoraro G; Lukas C; Lukas J; Nussenzweig A
Nucleic Acids Res; 2015 May; 43(10):4950-61. PubMed ID: 25916843
[TBL] [Abstract][Full Text] [Related]
14. Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Paes Dias M; Tripathi V; van der Heijden I; Cong K; Manolika EM; Bhin J; Gogola E; Galanos P; Annunziato S; Lieftink C; Andújar-Sánchez M; Chakrabarty S; Smith GCM; van de Ven M; Beijersbergen RL; Bartkova J; Rottenberg S; Cantor S; Bartek J; Ray Chaudhuri A; Jonkers J
Mol Cell; 2021 Nov; 81(22):4692-4708.e9. PubMed ID: 34555355
[TBL] [Abstract][Full Text] [Related]
15. [BRCA1 and BRCA2 - pathologists starting kit].
Škapa P
Cesk Patol; 2016; 52(4):193-196. PubMed ID: 27869444
[TBL] [Abstract][Full Text] [Related]
16. Ectopic RNF168 expression promotes break-induced replication-like DNA synthesis at stalled replication forks.
Krais JJ; Johnson N
Nucleic Acids Res; 2020 May; 48(8):4298-4308. PubMed ID: 32182354
[TBL] [Abstract][Full Text] [Related]
17. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
[TBL] [Abstract][Full Text] [Related]
18. RNF8 E3 Ubiquitin Ligase Stimulates Ubc13 E2 Conjugating Activity That Is Essential for DNA Double Strand Break Signaling and BRCA1 Tumor Suppressor Recruitment.
Hodge CD; Ismail IH; Edwards RA; Hura GL; Xiao AT; Tainer JA; Hendzel MJ; Glover JN
J Biol Chem; 2016 Apr; 291(18):9396-410. PubMed ID: 26903517
[TBL] [Abstract][Full Text] [Related]
19. Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.
Dedes KJ; Wilkerson PM; Wetterskog D; Weigelt B; Ashworth A; Reis-Filho JS
Cell Cycle; 2011 Apr; 10(8):1192-9. PubMed ID: 21487248
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.
Li L; Guturi KKN; Gautreau B; Patel PS; Saad A; Morii M; Mateo F; Palomero L; Barbour H; Gomez A; Ng D; Kotlyar M; Pastrello C; Jackson HW; Khokha R; Jurisica I; Affar EB; Raught B; Sanchez O; Alaoui-Jamali M; Pujana MA; Hakem A; Hakem R
J Clin Invest; 2018 Oct; 128(10):4525-4542. PubMed ID: 30222135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
